Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09SHH
|
||||
Former ID |
DIB013603
|
||||
Drug Name |
BAX-817
|
||||
Indication | Hemophilia [ICD9: 286; ICD10:D66-D68] | Phase 3 | [549120] | ||
Company |
Baxter International Inc
|
||||
Target and Pathway | |||||
Target(s) | Coagulation factor VII | Target Info | Inhibitor | [549853] | |
KEGG Pathway | Complement and coagulation cascades | ||||
PANTHER Pathway | Angiogenesis | ||||
Blood coagulation | |||||
PathWhiz Pathway | Coagulation | ||||
Reactome | BMAL1:CLOCK,NPAS2 activates circadian gene expression | ||||
Extrinsic Pathway of Fibrin Clot Formation | |||||
Gamma-carboxylation of protein precursors | |||||
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus | |||||
Removal of aminoterminal propeptides from gamma-carboxylated proteins | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.